Mammary epithelial cell transformation is associated with deregulation of the vitamin D pathway

Journal of Cellular Biochemistry

Volumn 105, Issue 4, 2008, Pages 980-988

  Kemmis, Carly M ^a   Welsh, JoEllen ^a,b  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Breast Cancer; Mammary; p53; Ras; Vitamin D

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 27B1; MESSENGER RNA; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; BREAST EPITHELIUM; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONCENTRATION (PARAMETERS); GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CALCITRIOL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; RECEPTORS, CALCITRIOL; RNA, MESSENGER; VITAMIN D;

EID: 55649115529     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21896     Document Type: Article

References (35)

1. Agadir A, Lazzaro G, Zheng Y, Zhang XK, Mehta R. 1999. Resistance of HBL100 human breast epithelial cells to vitamin D action. Carcinogenesis 20:577-582.
2. Agudo-Ibanez L, Nunez F, Calvo F, Berenjeno IM, Bustelo XR, Crespo P. 2007. Transcriptomal profiling of site-specific Ras signals. Cell Signal 19:2264-2276.
3. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D, Kuo WL, Gray JW, Pinkel D. 2000. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25:144-146.
4. Anderson MG, Nakane M, Ruan X, Kroeger PE, Wu-Wong JR. 2006. Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol 57:234-240.
5. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M. 2001. 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Commun 285:1012-1017.
6. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SR. 1994. Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31:191-202.
7. Cordes T, Diesing D, Becker S, Fischer D, Diedrich K, Friedrich M. 2007. Expression of splice variants of 1alpha-hydroxylase in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 103:326-329.
8. Cross HS, Bareis P, Hofer H, Bischof MG, Bajna E, Kriwanek S, Bonner E, Peterlik M. 2001. 25-Hydroxyvitamin D(3)-1alpha-hydroxylase and vitamin D receptor gene expression in human colonic mucosa is elevated during early cancerogenesis. Steroids 66:287-292.
9. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, Weinberg RA. 2001. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15:50-65.
10. Fischer D, Seifert M, Becker S, Ludders D, Cordes T, Reichrath J, Friedrich M. 2007. 25-Hydroxyvitamin D3 1alpha-hydroxylase splice variants in breast cell lines MCF-7 and MCF-10. Cancer Genomics Proteomics 4:295-300.
11. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, Sabatini DM, DeCaprio JA, Weinberg RA. 2002. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22:2111-2123.
12. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
13. Jurutka PW, MacDonald PN, Nakajima S, Hsieh JC, Thompson PD, Whitfield GK, Galligan MA, Haussler CA, Haussler MR. 2002. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor. J Cell Biochem 85:435-457.
14. Kemmis CM, Salvador SM, Smith KM, Welsh JE. 2006. Human mammary epithelial cells express CYP27b1 and are growth inhibited by 25-hydroxyvitamin D-3, themajor circulating form of vitamin D-3. J Nutr 136:887-892.
15. Kommagani R, Caserta TM, Kadakia MP. 2006. Identification of vitamin D receptor as a target of p63. Oncogene 25:3745-3751.
16. Kommagani R, Payal V, Kadakia MP. 2007. Differential regulation of vitamin D receptor (VDR) by the p53 family: p73-depdendent induction of VDR upon DNA damage. J Biol Chem 282:29847-29854.
17. Ly LH, Zhao XY, Holloway L, Feldman D. 1999. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity. Endocrinology 140:2071-2076.
18. Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, Mita H, Suzuki H, Akino K, Ohe-Toyota M, Maruyama Y, Tatsumi H, Imai K, Shinomura Y, Tokino T. 2006. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 66:4574-4583.
19. Masuda S, Gao M, Zhang A, Kaufmann M, Jones G. 2003. Importance of cytochrome P450-mediated metabolism in the mechanism of action of vitamin D analogs. Recent Res Cancer Res 164:189-202.
20. Mehta RG, Moriarty RM, Mehta RR, Penmasta R, Lazzaro G, Constantinou A, Guo L. 1997. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5. J Natl Cancer Inst 89:212-218.
21. Mimori K, Tanaka Y, Yoshinaga K, Masuda T, Yamashita K, Okamoto M, Inoue H, Mori M. 2004. Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. Ann Oncol 15:236-241.
22. Narvaez CJ, Byrne BM, Romu S, Valrance M, Welsh JE. 2003. Induction of apoptosis by 1,25-dihydroxyvitamin D3 in MCF-7 vitamin D3-resistant variant can be sensitized by TPA. J Steroid Biochem Mol Biol 84:199-209.
23. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, Quintanilla M, Cano A, de_Herreros AG, Lafarga M, Munoz A. 2001. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154:369-387.
24. Pendas-Franco N, Gonzalez-Sancho JM, Suarez Y, Aguilera O, Steinmeyer A, Gamallo C, Berciano MT, Lafarga M, Munoz A. 2007. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 75:193-207.
25. Radermacher J, Diesel B, Seifert M, Tilgen W, Reichrath J, Fischer U, Meese E. 2006. Expression analysis of CYP27b1 in tumor biopsies and cell cultures. Anticancer Res 26:2683-2686.
26. Rowling MJ, Kemmis CM, Taffany DA, Welsh JE. 2006. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25- hydroxycholecalciferol actions in human mammary cells. J Nutr 136:2754-2759.
27. Rozenchan PB, Folgueira MA, Katayama ML, Snitcovsky IM, Brentani MM. 2004. Ras activation is associated with vitamin D receptor mRNA instability in HC11 mammary cells. J Steroid Biochem Mol Biol 92:89-95.
28. Solomon C, Sebag M, White JH, Rhim J, Kremer R. 1998. Disruption of vitamin D receptor-retinoid X receptor heterodimer formation following ras transformation of human keratinocytes. J Biol Chem 273:17573-17578.
29. Stedman L, Nickel KP, Castillo SS, Andrade J, Burgess JR, Teegarden D. 2003. 1,25-dihydroxyvitamin D inhibits vitamin E succinate-induced apoptosis in C3H10T1/2 cells but not Harvey ras-transfected cells. Nutr Cancer 45:93-100.
30. Townsend K, Banwell CM, Guy M, Colston KW, Mansi JL, Stewart PM, Campbell MJ, Hewison M. 2005. Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res 11:3579-3586.
31. Vaisanen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C. 2005. Spatiotemporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. J Mol Biol 350:65-77.
32. Wu S, Ren S, Nguyen L, Adams JS, Hewison M. 2007. Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 148:3410-3418.
33. Zinser GM, Welsh JE. 2004. Accelerated mammary gland development during pregnancy and delayed post-lactational involution in vitamin D3 receptor null mice. Mol Endocrinol 18:2208-2223.
34. Zinser GM, Packman K, Welsh JE. 2002. Vitamin D(3) receptor ablation alters mammary gland morphogenesis. Development 129:3067-3076.
35. Zinser GM, McEleney K, Welsh JE. 2003. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice. Mol Cell Endocrinol 200:67-80.